Your browser doesn't support javascript.
loading
A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nausea and vomiting in cancer patients.
Dranitsaris, George; Moezi, Mehdi; Dobson, Kate; Phelan, Robert; Blau, Sibel.
Afiliación
  • Dranitsaris G; Health Economics and Outcomes Research Unit, Quality Care Cancer Alliance, 1624 S. "I" Street, Suite 305, Tacoma, WA, 98405, USA. George.dranitsaris@gmail.com.
  • Moezi M; Department of Public Health, Falk College, Syracuse University, Syracuse, NY, USA. George.dranitsaris@gmail.com.
  • Dobson K; Cancer Specialists of North Florida, Jacksonville, FL, USA.
  • Phelan R; Health Economics and Outcomes Research Unit, Quality Care Cancer Alliance, 1624 S. "I" Street, Suite 305, Tacoma, WA, 98405, USA.
  • Blau S; Health Economics and Outcomes Research Unit, Quality Care Cancer Alliance, 1624 S. "I" Street, Suite 305, Tacoma, WA, 98405, USA.
Support Care Cancer ; 30(8): 6649-6658, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35499619

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antieméticos / Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antieméticos / Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania